148 related articles for article (PubMed ID: 38085705)
1. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
Kaminski CY; Galindo RJ; Navarrete JE; Zabala Z; Moazzami B; Gerges A; McCoy RG; Fayfman M; Vellanki P; Idrees T; Peng L; Umpierrez GE
Diabetes Care; 2024 Feb; 47(2):267-271. PubMed ID: 38085705
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
[TBL] [Abstract][Full Text] [Related]
3. Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine.
Desouza CV; Rosenstock J; Kohzuma T; Fonseca VA
J Clin Endocrinol Metab; 2023 Oct; 108(11):e1193-e1198. PubMed ID: 37259605
[TBL] [Abstract][Full Text] [Related]
4. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
[TBL] [Abstract][Full Text] [Related]
5. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
[TBL] [Abstract][Full Text] [Related]
6. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
[TBL] [Abstract][Full Text] [Related]
7. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study.
Jung M; Warren B; Grams M; Kwong YD; Shafi T; Coresh J; Rebholz CM; Selvin E
J Diabetes; 2018 Apr; 10(4):276-285. PubMed ID: 29055090
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin A
Chan CL; Hope E; Thurston J; Vigers T; Pyle L; Zeitler PS; Nadeau KJ
Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
[TBL] [Abstract][Full Text] [Related]
9. Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients.
Lee SY; Chen YC; Tsai IC; Yen CJ; Chueh SN; Chuang HF; Wu HY; Chiang CK; Cheng HT; Hung KY; Huang JW
PLoS One; 2013; 8(3):e57762. PubMed ID: 23469230
[TBL] [Abstract][Full Text] [Related]
10. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
[TBL] [Abstract][Full Text] [Related]
11. Glycated albumin as biomarker: Evidence and its outcomes.
Kohzuma T; Tao X; Koga M
J Diabetes Complications; 2021 Nov; 35(11):108040. PubMed ID: 34507877
[TBL] [Abstract][Full Text] [Related]
12. Association of time in range with hemoglobin A1c, glycated albumin and 1,5-anhydro-d-glucitol.
Ohigashi M; Osugi K; Kusunoki Y; Washio K; Matsutani S; Tsunoda T; Matsuo T; Konishi K; Katsuno T; Namba M; Koyama H
J Diabetes Investig; 2021 Jun; 12(6):940-949. PubMed ID: 33058513
[TBL] [Abstract][Full Text] [Related]
13. Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis.
Gallieni M; De Salvo C; Lunati ME; Rossi A; D'Addio F; Pastore I; Sabiu G; Miglio R; Zuccotti GV; Fiorina P
Acta Diabetol; 2021 Aug; 58(8):975-981. PubMed ID: 33743082
[TBL] [Abstract][Full Text] [Related]
14. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
[TBL] [Abstract][Full Text] [Related]
15. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
[TBL] [Abstract][Full Text] [Related]
16. Glycated albumin in diabetic patients with chronic kidney disease.
Zheng CM; Ma WY; Wu CC; Lu KC
Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
[TBL] [Abstract][Full Text] [Related]
17. Results of a Study Comparing Glycated Albumin to Other Glycemic Indices.
Desouza CV; Holcomb RG; Rosenstock J; Frias JP; Hsia SH; Klein EJ; Zhou R; Kohzuma T; Fonseca VA
J Clin Endocrinol Metab; 2020 Mar; 105(3):677-87. PubMed ID: 31650161
[TBL] [Abstract][Full Text] [Related]
18. Is there a "burnt-out diabetes" phenomenon in patients on hemodialysis?
Abe M; Hamano T; Hoshino J; Wada A; Inaba M; Nakai S; Masakane I
Diabetes Res Clin Pract; 2017 Aug; 130():211-220. PubMed ID: 28648854
[TBL] [Abstract][Full Text] [Related]
19. GLYCATED ALBUMIN AT 4 WEEKS CORRELATES WITH A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS.
Desouza CV; Rosenstock J; Zhou R; Holcomb RG; Fonseca VA
Endocr Pract; 2015 Nov; 21(11):1195-203. PubMed ID: 26214108
[TBL] [Abstract][Full Text] [Related]
20. Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.
Juraschek SP; Steffes MW; Selvin E
Clin Chem; 2012 Dec; 58(12):1648-55. PubMed ID: 23019309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
